Student Login |


Sunday, December 04, 2022
Home » Clinical Trial Safety Reporting Requirements in the EU and USA

Clinical Trial Safety Reporting Requirements in the EU and USA

Certification TrainingProgram/Course ID: CT14
Enrollment Period: 6 months.
Average Learning Time: ~120 minutes.
Additional Resources: Supplemental materials/activities.
Accredited Program: 2 CPD Credits.
Method of Training: Online / Self-paced eLearning.
Accessibility: 24/7 access to all program materials.
CPD Accredited TrainingCatalog: Drug Safety.
Demonstration: Five (5) free trial courses are available.
Group/Employee Training: Click here to request a quote.
Final Assessment: Multiple choice; unlimited attempts.
Certificate: PDF with validation code (See sample).
  Price: $225.00 USD  

Document your dedication to quality, compliance, safety, and job performance by earning a training certification.

Training Program: Clinical Trial Safety Reporting Requirements in the EU and USA
Training Provided By: Biopharma Institute
Website: https://www.biopharmainstitute.com

Schedule: Self-paced. Immediate access to training materials upon enrollment.

Description:
Biopharma Institute ReviewsThis course sets out the legal and regulatory requirements for safety reporting in clinical trials of medicinal products under the jurisdictions of the European Union and the USA. It builds on the foundation laid by our companion course CT13, Safety Reporting in Clinical Trials, and provides greater detail of specific requirements in those jurisdictions.

Certification Requirements: Students must view the entire course and successfully pass an online, multiple-choice final assessment within a 6-month period, or a 12-month period for professional certification programs. A certificate of completion is immediately accessible in PDF format after satisfying the requirements.

Biopharma Institute certificates and digital badges include the date of completion, but do not have an expiration date. However, compliance training is typically considered valid for a period of 3 years. Many organizations suggest that compliance training should be refreshed at least every three years to stay up to date with regulations, standards, guidelines, and to reinforce the importance of maintaining compliance. The validity period for employee compliance training would be determined by those responsible for managing quality assurance.

Biopharma Institute's online training courses include immediate access after enrollment. Username, password, and instructions are emailed to the student directly following online enrollment into the program. Course takers may attempt the final assessment any number of times, as needed, to achieve a passing score. The certificate of completion is instantaneously launched and made available to the student in a PDF format upon completion.

Once all training requirements have been satisfied the achievement can be verified from our website using the unique ID code found on the certificate. Professional certification programs issue a digital badge to verify training and document the achievement. These digital badges can be displayed on social networking sites, such as LinkedIn, Facebook, Twitter, and Badgr.


Outline:


Legal and regulatory requirements in the EU
In this session, we set out the legal and regulatory requirements for safety reporting under the EU Clinical Trials Regulation. We specify the responsibilities of investigators and those of sponsors. We distinguish those reports that must be submitted by sponsors to the EudraVigilance portal and those that must be submitted to the Clinical Trials Information System. We specify the format and terminology that must now be used, and we identify the tools and pathways for electronic submission. Finally, we outline significant differences in requirements under the Clinical Trials Directive.

Legal and regulatory requirements in the USA
In this session, we set out the legal and regulatory requirements for safety reporting in clinical trials conducted (in the USA or elsewhere) under an Investigational New Drug application (IND) to the US Food and Drug Administration (FDA). We specify the responsibilities of investigators and those of sponsors. We describe the criteria for IND safety reports to the FDA, and the content, format and timing of their submission. We discuss investigators' obligation to report unanticipated problems to institutional review boards. Finally, we discuss IND annual reports and other safety reporting issues.

Assessment
Multiple-choice mastery assessment.

Objectives:


Level: Intermediate/advanced
Audience: Clinical research, drug safety, and regulatory affairs staff, healthcare professionals
Category: Clinical trials, drug safety, regulatory affairs
Region: Europe, USA

Who will benefit from this course?
This course provides essential information for clinical research, drug safety, and regulatory affairs staff of sponsors of clinical trials, as well as investigators and other healthcare professionals who undertake clinical trials.

Learning objectives
  • Identify relevant EU statutes and sources of regulatory guidance
  • Identify online portals that are key to safety reporting in clinical trials in the EU
  • Summarize investigators' and sponsors' responsibilities under the Clinical Trials Regulation
  • Discuss the role of reference safety information in the EU
  • Specify sponsors' responsibilities for reporting suspected unexpected serious adverse reactions in the EU
  • Describe how to submit electronic reports to EudraVigilance
  • Outline sponsors' responsibilities for reporting SUSARs to investigators under the Clinical Trials Regulation
  • Identify submissions that sponsors must make to the EU Clinical Trials Information System
  • Outline significant differences in requirements under the Clinical Trials Directive
  • Identify relevant US statutes and sources of regulatory guidance
  • Summarize clinical investigators' responsibilities for reporting to sponsors of trials conducted under an Investigational New Drug application (IND) to the US Food and Drug Administration (FDA)
  • Discuss the assessment of causality of serious adverse events
  • Summarize sponsors' responsibilities for review of safety information under an IND
  • Specify sponsors' responsibilities for IND safety reporting to FDA and investigators
  • Describe how to deal with anticipated events according to FDA guidance
  • Specify timeframes for IND safety reporting
  • Specify requirements for analysis of similar events and submission of follow-up information
  • Describe how to submit IND safety reports to the FDA
  • Discuss requirements for electronic submission of IND safety reports
  • Discuss requirements for investigators' reporting of unanticipated problems to investigational review boards
  • Specify sponsors' responsibilities for submission of IND annual reports

Benefits of Training with Biopharma Institute

  • Immediate access to training: Instructions, username, password, and receipt of payment are emailed instantly upon online enrollment.
  • Self-paced courses: 24/7 access to individual courses for 6 months and 1 year for professional certification programs.
  • Expertise: All courses have been developed by subject matter experts (SMEs) in the area of material being taught.
  • Current and validated: All courses are current with respect to regulations and procedures, and are 3rd party validated and/or accredited.
  • Optimized for learning: Courses include voiceovers, easy navigation, case studies, progress checks, and high-quality animations to increase retention of subject matter.
  • Secure and safe access: Website and LMS provide an encrypted connection with firewall protection and daily scans for malware to deliver optimal level of security and performance.
  • Training manager access: Our proprietary Training Manager Portal offers managers access to download their group enrollments, training records, account balance, and so much more.
  • Purchase orders (POs): If issuing a PO is required by your company, request an invoice to start the procurement process.
  • Corporate LMS compatibility: All courses are SCORM compliant and can be delivered from most corporate Learning Management Systems.
  • Reimbursement: Some employers may reimburse for training expenses. Check your company's training reimbursement policy.
  • Financial assistance: Payment plans are available to those who qualify. These are offered when paying electronic invoices, online. You must first request an invoice to be considered. Alternatively, purchasing individual courses one at a time is also an option.
  • Flexible final assessments: Assessments include multiple-choice questions and can be taken repeatedly until a passing score is achieved.
  • Career advancement: Professional certifications help demonstrate your interest and dedication to your career and job performance. They may be helpful for those seeking a new career or transitioning to different positions within their organization.
  • Direct access to certificates: Certificate of completion is instantly available once requirements have been fulfilled.
  • Verification of training: Certificates can be verified online, and digital badges are issued for all professional certification programs.


Have Questions? Contact Us:

Use the form below if you would like more information on our programs. You may want to request a quote on group training or an invoice for generating a company purchase order. For quotes or invoices please provide the course(s) and number of students. Alternatively, call toll-free from the US or Canada: +1 (888) 424-6576. International callers may dial: +1 (201) 301-8370.

Name:
Company:
Phone:
Email:
 
Enter the number from the image above:
Comments:


For quotes or invoices please provide the course(s) and number of students.